155 related articles for article (PubMed ID: 9034592)
21. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells.
Ohta Y; Kijima H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
Nucleic Acids Res; 1996 Mar; 24(5):938-42. PubMed ID: 8600463
[TBL] [Abstract][Full Text] [Related]
22. Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.
Flory CM; Pavco PA; Jarvis TC; Lesch ME; Wincott FE; Beigelman L; Hunt SW; Schrier DJ
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):754-8. PubMed ID: 8570629
[TBL] [Abstract][Full Text] [Related]
23. Reversible covalent attachment of cholesterol to oligodeoxyribonucleotides for studies of the mechanisms of their penetration into eucaryotic cells.
Boutorine AS; Kostina EV
Biochimie; 1993; 75(1-2):35-41. PubMed ID: 8504175
[TBL] [Abstract][Full Text] [Related]
24. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells.
Yaswen P; Stampfer MR; Ghosh K; Cohen JS
Antisense Res Dev; 1993; 3(1):67-77. PubMed ID: 8495107
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites.
Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3501-5. PubMed ID: 8475098
[TBL] [Abstract][Full Text] [Related]
27. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
Krieg AM; Tonkinson J; Matson S; Zhao Q; Saxon M; Zhang LM; Bhanja U; Yakubov L; Stein CA
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1048-52. PubMed ID: 8430072
[TBL] [Abstract][Full Text] [Related]
28. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity.
Shore SK; Nabissa PM; Reddy EP
Oncogene; 1993 Nov; 8(11):3183-8. PubMed ID: 8414522
[TBL] [Abstract][Full Text] [Related]
29. Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila.
Zhao JJ; Pick L
Nature; 1993 Sep; 365(6445):448-51. PubMed ID: 8413588
[TBL] [Abstract][Full Text] [Related]
30. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.
Fisher TL; Terhorst T; Cao X; Wagner RW
Nucleic Acids Res; 1993 Aug; 21(16):3857-65. PubMed ID: 8396239
[TBL] [Abstract][Full Text] [Related]
31. Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity.
Giles RV; Spiller DG; Tidd DM
Anticancer Drug Des; 1993 Feb; 8(1):33-51. PubMed ID: 8386514
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
Stein CA; Cheng YC
Science; 1993 Aug; 261(5124):1004-12. PubMed ID: 8351515
[TBL] [Abstract][Full Text] [Related]
33. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
Bergan R; Connell Y; Fahmy B; Neckers L
Nucleic Acids Res; 1993 Jul; 21(15):3567-73. PubMed ID: 8346033
[TBL] [Abstract][Full Text] [Related]
34. Current concepts in antisense drug design.
Milligan JF; Matteucci MD; Martin JC
J Med Chem; 1993 Jul; 36(14):1923-37. PubMed ID: 8336333
[No Abstract] [Full Text] [Related]
35. Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line.
Snyder DS; Wu Y; Wang JL; Rossi JJ; Swiderski P; Kaplan BE; Forman SJ
Blood; 1993 Jul; 82(2):600-5. PubMed ID: 8329715
[TBL] [Abstract][Full Text] [Related]
36. Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O.
Barry EL; Gesek FA; Friedman PA
Biotechniques; 1993 Dec; 15(6):1016-8, 1020. PubMed ID: 8292333
[TBL] [Abstract][Full Text] [Related]
37. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphorothioates in mice.
Temsamani J; Tang JY; Padmapriya A; Kubert M; Agrawal S
Antisense Res Dev; 1993; 3(3):277-84. PubMed ID: 8286928
[TBL] [Abstract][Full Text] [Related]
39. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
Wright L; Wilson SB; Milliken S; Biggs J; Kearney P
Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570
[TBL] [Abstract][Full Text] [Related]
40. Oligonucleotide clamps arrest DNA synthesis on a single-stranded DNA target.
Giovannangeli C; Thuong NT; Hélène C
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10013-7. PubMed ID: 8234249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
